Barclays lowered the firm’s price target on James Hardie (JHX) to $22 from $26 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the homebuilding and building products space as part of a Q1 earnings preview. Barclays favors building products and distributor names with pricing power and/or vertical integration. Investors should continue to avoid homebuilders as 2026 “shapes up to be a potential lost year,” the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JHX:
- James Hardie: Compelling Buy After Share Price Pullback Amid Resilient Fundamentals and Undervalued Growth
- James Hardie Earnings Call: Synergies Rise, Core Softens
- James Hardie price target raised to $26 from $21 at Barclays
- James Hardie price target raised to $30 from $28 at Truist
- James Hardie upgraded to Overweight from Neutral at JPMorgan
